6Paavonen K, Puolakainen P, jussila L, et al. Vascular endothelial growth factor receptor - 3 in lymphangiogenesis in wound healing[J]. Am J Pathoh, 2000, 156(50): 1499 - 1505.
7Valtola R, Salven P, heikkila P, et al. VEGFR - 3 andits ligand VEGF - C are associated with angiogenesisinbreast cancer[J]. Am J Pathol, 1999, 154(5): 1381 - 1390.
8Skobe M, Brown LF, Togazzi K, et al. Vascular endothelial growth factor - C(VEGF - C) and its receptors KDR and fit - 4are Expressed in AIDS- Associated Kaposis Sarcoma[J]. J Invest Dermatol, 1999, 113 (6): 1047-1053.
9Soker S, Takashima S, Miao HQ, et al. Nuropilin- 1 is expressed by endothelial and tumor cells as an isofrom specific receptor for vascular endothelial growth factor[J]. Cell, 1998,(92) :735 - 745.
10Neufeld G, Cohen T, Gengrinovitch S, et al. Vascular endothelial growth factor (VEGF) and its receptors [J]. FASEB J, 1999, 13:9-22.
二级参考文献4
1DetmarM,BrownLF,ClaffeyKP,etal.Overexpressionofvascularpermeabilityfactor/vascularendothelialgrowthfactoranditsreceptorsinpsoriasis[].The Journal of Experimental Medicine.1994
7Dinarello CA.Interleukin-18 and the pathogenesis of inflammatory diseases[J].Semin Nephrol,2007,27 (1):98-114.
8Lew W,Lee E,Krueger JG.Psoriasis genomics:analysis of proinflammatory (type 1) gene expression in large plaque (Western) and small plaque (Asian) psoriasis vulgaris[J].Br J Dermatol,2004,150(4):668-676.
9Friedrich M,Krammig S,Henze M,et al.Flow cytometric characterization of lesional T cells in psoriasis:intracellular cytokine and surface antigen expression indicates an activated,memory/effector type 1 immunophenotype[J].Arch Dermatol Res,2000,292(10):519-521.
10Kanda N,Shimizu T,Tada Y,et al.IL-18 enhances IFN-gamma-induced production of CXCL9,CXCL10,and CXCL11 in human keratinoeytes[J].Eur J Immunol,2007,37(2):338-350.
